
Compugen Ltd
NASDAQ:CGEN

Intrinsic Value
The intrinsic value of one
CGEN
stock under the Base Case scenario is
1.44
USD.
Compared to the current market price of 1.41 USD,
Compugen Ltd
is
Undervalued by 2%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Compugen Ltd
Fundamental Analysis


Revenue & Expenses Breakdown
Compugen Ltd
Balance Sheet Decomposition
Compugen Ltd
Current Assets | 106m |
Cash & Short-Term Investments | 103.3m |
Receivables | 2.7m |
Non-Current Assets | 9m |
Long-Term Investments | 3.1m |
PP&E | 3.7m |
Other Non-Current Assets | 2.2m |
Free Cash Flow Analysis
Compugen Ltd
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Compugen Ltd
Revenue
|
27.9m
USD
|
Cost of Revenue
|
-7.9m
USD
|
Gross Profit
|
19.9m
USD
|
Operating Expenses
|
-34.8m
USD
|
Operating Income
|
-14.9m
USD
|
Other Expenses
|
660k
USD
|
Net Income
|
-14.2m
USD
|
CGEN Profitability Score
Profitability Due Diligence
Compugen Ltd's profitability score is 30/100. The higher the profitability score, the more profitable the company is.

Score
Compugen Ltd's profitability score is 30/100. The higher the profitability score, the more profitable the company is.
CGEN Solvency Score
Solvency Due Diligence
Compugen Ltd's solvency score is 56/100. The higher the solvency score, the more solvent the company is.

Score
Compugen Ltd's solvency score is 56/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CGEN Price Targets Summary
Compugen Ltd
According to Wall Street analysts, the average 1-year price target for
CGEN
is 4.85 USD
with a low forecast of 4.04 USD and a high forecast of 7.35 USD.
Dividends
Current shareholder yield for CGEN is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
CGEN
stock under the Base Case scenario is
1.44
USD.
Compared to the current market price of 1.41 USD,
Compugen Ltd
is
Undervalued by 2%.